Introduction
Stereopsis is routinely measured at near as part of the clinical assessment of patients with disorders of ocular motility and strabismus. Recently the FD2 [1, 2] has been introduced in order to measure stereopsis at distance. The present of stereopsis at a given distance indicates that a patient has binocular control at that position. Binocular control can vary with distance depending on the state of the patient's ocular alignment. It is important therefore, to assess stereopsis at different distances in the clinical environment.
Stereopsis is usually reserved for the impression of depth arising from binocular disparity [3] [4] [5] . There are, however, many other binocular (vergence, luminance, chromostereopsis, texture, etc.) and monocular (parallax, size, luminance, etc.) cues that provide important depth information [6, 7] . These cues vary in the different stereoacuity tests, whether real object (Frisby, VDS, FD2) or simulated (TNO, BVAT, Titmus). The sum of these cues contributes to a combined threshold of depth discrimination (CT) [8] which is actually what is measured by most available stereoacuity tests. It is because these cues vary in different tests and with different viewing distances and gaze positions, that differences in measured "stereoacuity" thresholds are often found.
Until the introduction of distance stereoacuity tests, assessment of binocular alignment when viewing distant objects relied upon the absence of a detectable heterotropia and the response to Bagolini striated lenses or the Worth 4 Dot test. Neither test, however, provides sufficient information to demonstrate the present of stereopsis. The FD2 is a real object or depth rather than simulated stereoacuity test. Although it is, therefore, not prone to disassociative stimuli, because it is a real object test, it is prone to monocular cues and limited in its range.
The use of the FD2 to evaluate the success of exotropia surgery has been evaluated [9] but it is unclear, however, whether the use of a real depth test such as the FD2 contributes to the actual clinical management of patients with disorders of ocular motility. The contribution of the FD2 to the management of a group of patients was therefore investigated. 
Methods
A retrospective case note review of 73 consecutive adult patients with disorders of ocular motility who, had been under review before and following the introduction of the FD2 were included. They were divided into 4 groups according to whether their depth discrimination could be measured for; both near and distance, only at one distance, or not at either distance. Patients in each group were then assessed according to whether there had been a change in their management and whether this was based in part on the information provided by the FD2. A prospective study was undertaken on 50 healthy individuals to determine the monocular thresholds and normative data of the stereoacuity tests that had been used.
Ocular Alignment and Visual
Acuity. Ocular deviations were measured (using alternate prism and cover test) in prism dioptres (rounded to nearest 2PD for deviations up to and including 20PD, and the nearest 5PD for deviations greater than 20PD). Monocular near and distance best corrected visual acuity (BCVA) was measured at 6 m using Snellen chart and at 0.33 m, using a near reading type.
Measurement of Depth Discrimination.
Stereoacuity tests were used according to the manufacturer's instructions. Depth discrimination thresholds were measured at near (between 0.3 m and 0.8 m) using either the TNO or Frisby stereoacuity tests in the normal reading position (i.e., on downgaze) and at distance (6 m) using the FD2. The range of thresholds for the Frisby for each of the 3 plates can only be varied by changing the viewing distance, and the measured thresholds were at the distances specified between 0.3 m and 0.8 m by the manufacturer. The FD2 comprises of a box containing four back illuminated shapes mounted on rods, in a transparent support frame. Each of the shapes can be moved so that one of them is set nearer than the other three shapes. The rods are marked, so that disparity can be set between 5 and 50 seconds of arc in steps of 5 seconds. The FD2 was positioned at the correct measured height for each subject's eye level, and patients were asked not to move their head during testing. The subjects were required to identify three out of four correct choices at a given disparity until the patient reached threshold. In the control group thresholds of depth discrimination [6].
Analysis.
Chi-squared test was used to test for a difference between the patient groups. The logarithm of the depth discrimination threshold (combined, monocular, and binocular) was used for the analysis. For comparison between the stereoacuity tests in the control group a repeated measures model was used.
Results

Control
Group. 50 healthy subjects (mean age 38 years (12)) were included. Using the FD2, MT was not measurable at 6 m. At 3 m MT was measurable in 10% and at 1 m in 60% of subjects (Table 1 ). There were linear but relatively weak associations between the FD2 at 6 m and the Frisby (R 2 = 0.40, P < .001) and TNO (R 2 = 0.28, P < .001) tests. There was also a significant association between age and depth discrimination (both near P = .003 and distance P = .002).
3.2.
Patients. 73 adult patients were included (mean age 58.3 years (19.5)). There were 39 patients whose depth discrimination thresholds could be measured at both distances (FD2 and near test positive), and 6 patients whose depth discrimination could not be measured with either test (FD2 and near test negative). There were 22 patients whose depth discrimination thresholds could be measured at near only, and 6 patients whose depth discrimination could be measured at distance only. Nine of the patients who had incongruous results with the near and FD2 tests had a Journal of Ophthalmology 3 change in management. Overall 23 patients had a change in management, the FD2 contributing in part to this decision (Table 2) . Table 2 ) had stereoacuity measurable only on the FD2. Four of these patients had torsional misalignment more evident for near on depression. Two patients had a variable angle at near with no measurable near depth discrimination. Prior to the introduction of the FD2 these six patients had been thought to have no useful stereopsis based on near stereoacuity tests placed in the normal reading position, that is, downgaze. Using the FD2 however they had measurable depth discrimination (mean 38.3 seconds) at 6 m with a prism in place. Prisms were therefore prescribed.
FD2 Positive, Near Negative. Six patients (68-73
FD2 Negative, Near
Positive. Patients 20 and 22 (Table 2) had no stereopsis measurable at distance. The first patient, had his prism reduced on his distance spectacle segment, as using the FD2 no achievable stereopsis could be demonstrated at distance. A second patient, who had previously demonstrated 15 seconds with the FD2, lost this function due to a change in his ocular alignment associated with deterioration of his thyroid eye disease. This patient did not show any change in his near depth threshold, which remained at 55 seconds. A third patient (number 21) had a decompensating exophoria and was found to have lost their distance stereopsis (previously 50 seconds) and 2 lines of BCVA (from 6/5 to 6/9) but with no change in their near stereoacuity. This patient was found to have had a recurrent retinal detachment and was therefore excluded from further analysis.
FD2 and Near
Positive. Patients 48 to 61 (Table 2) had stereoacuity measurable on both the FD2 and near tests. In ten of these fourteen patients, the FD2 was used to determine at what distance a prism was required and how much prism was necessary to gain stereoacuity. In patients undergoing surgery for strabismus, the FD2 was used to confirm the presence of quantifiable binocular function at the corrected angle for distance in free space. Overall, patients who had evidence of depth discrimination stereopsis using the FD2 were significantly more likely to have some modifications to their clinical management than expected from the whole patient sample (P = .023). This was particularly so for patients who had evidence of depth discrimination on the FD2 but not using the near tests (P < .001).
Discussion
The most commonly used stereo tests in clinical practice are usually viewed at near. In addition, many adult patients wear bifocals or varifocals requiring that the near stereo tests be placed in their normal reading position. Distance stereoacuity using the FD2 is measured at eye level. One therefore cannot assume that because an individual has stereoacuity at near or in a reading position, that they will also have stereoacuity at distance in the primary position.
For example, in this study some patients achieved 25 seconds using the FD2 but only achieved 120 seconds using the Frisby at 0.4 m. It is unclear whether this difference arose because of changes in ocular position or differences in the inherent monocular and binocular cue content in each test. This is apparent in the relatively poor correlation between near tests and FD2.
Importantly we found that for the patients in this study, the demonstration of stereopsis at distance contributed to a change in their management. Although it is difficult to be sure of the true contribution of the FD2 to the change in management given that a change in condition could have occurred before and after introduction of FD2, this is unlikely as most of the patients' ocular motility was relatively stable. Similarly whilst it is possible that a similar proportion of patients may have had a change in their management in the absence of the results of the FD2, this is also unlikely, given that the management decisions were influenced by the results of the FD2.
The relatively poor association between the TNO, Frisby, and FD2 for the healthy control where the maximum association was 40% and for patient group, where there was no significant association, is likely to reflect the differences in the monocular and binocular cue content of these tests. For example, although vertical disparity, accommodation, and vergence are potentially important binocular cues for near tests, they may play less of a role in distance stereoacuity tests [6, [10] [11] [12] [13] [14] [15] [16] [17] [18] . These differences in monocular and binocular cues are also likely to account in part for the differences in measured thresholds. For example, although all of the patients who were near positive but distance negative had near stereoacuity values greater than 50 seconds, there were many patients who had near and distance stereoacuity with distance stereoacuity less than 50 seconds, despite their near stereoacuity values being greater than 50 seconds of arc.
The targets used in the near stereoacuity tests have minimum and maximum thresholds of 15 seconds and 1980 seconds (TNO) and 20 seconds and 600 seconds (Frisby). In contrast the FD2 at 6 m has a minimum and maximum threshold of 5 seconds and 50 seconds. This together with the noncontinuous or stepwise increments in all of these stereoacuity tests means that there is little overlap between the near tests and the FD2.
This limitation may account for those patients who had thresholds greater than 50 seconds with near tests but who had no demonstrable stereopsis using the FD2 at 6 m. Shortening of the viewing distance to 3 m extends the maximum threshold with the FD2, but also leads to an increase in monocular cues [19] , see Table 1 . Monocular cues facilitate depth perception and form an integral part of the stereo mechanism [6, 20] , and it has been shown that monocular cues may contribute to depth even when they do not reach threshold [6] . Previous investigations of the FD2 have reported a problem with the monocular cue content [21] thus necessitating either a change in protocol or measurement of the monocular threshold. As discussed, although stereopsis is usually reserved for the impression of depth arising from binocular disparity [3] [4] [5] 8] horizontal and nonhorizontal [12, 20] other binocular Table 2 : Patients who had a change in clinical management following introduction of FD2. Patients 68-73 had evidence of stereopsis using the FD2 but not with near tests, patients 20-22, stereopsis with the near tests but not FD2 and patients 48-61 evidence of stereopsis with both the FD2 and near tests, respectively. Patient 21 was excluded from further analysis as the change was due to retinal detachment. Summary of the change in management is included in the right-most column. Diagnosis is included where established. Where no specific diagnosis established, extraocular muscle deviation recorded. Prism dioptres (pd), intermittent heterotropia (T), esophoria (EP), esotropia (ET), hyper or hypotropia (HT), hyper or hypophoria (HP), base-out (BO), and base-in (BI) prism, lateral rectus (LR), superior rectus (SR), superior oblique (SO), medial rectus (MR), inferior rectus (IR), right (R) and left (L), underaction (u/a), thyroid eye disease (TED [6, 7] . These cues summate in any stereoacuity test so that what is measured is a combined threshold of depth discrimination [8] . It has, however, been shown that subtraction of the monocular threshold from the combined threshold allows calculation of the actual binocular threshold (BT) of depth discrimination [6] which, is what is of interest when assessing binocularity. Thus when measuring a patient's level of stereoacuity if monocular cues reach threshold, rather than abandoning the test, the monocular threshold should be subtracted from the binocular threshold according to the function, BT = (1/CT-1/MT) −1 [6, 7, 19, 20] . Other distance stereoacuity tests have been introduced such as the Mentor Binocular Video Acuity Tester (BVAT) [22] [23] [24] and the Variable Distance Stereotest (VDS) [3, 6] . The importance of measuring stereoacuity at distance has been particularly well demonstrated using the BVAT and VDS. The BVAT is a simulated distance stereotest. The test requires the use of goggles that are potentially disassociative and do not facilitate the correction of any deviation using prisms. The BVAT being a simulated test has zero parallax, which implies that the object is flat. The VDS based on the classic three-rod arrangement of Helmholtz [25] , and although providing a continuous measurement of stereoacuity in seconds of arc has never been commercially available.
The introduction into clinical practice of the FD2 distance stereotest was found to contribute to clinical decision making which otherwise may not have occurred using only near stereoacuity tests. The FD2 is however limited by its range at 6 meters and using the test at shorter distances necessitates measurement of MT with calculation of the BT as described above. Despite these limitations measurement of stereoacuity at distance is an important aspect in the evaluation of patients with disorders of ocular motility.
